CDD news

CDD appoints PhD dietitian to support patients

The CDD has appointed PhD Dietitian Annabel Clancy to support and guide patients on dietary matters before and after procedures and treatments at the CDD. Annabel graduated from the University of Wollongong with a Bachelor of Nutrition and Dietetics with honours. She is an Accredited Practicing Dietitian at the Centre for Digestive Diseases, supporting the dietary […]

CDD featured in the media, CDD news

The Australian | Prof. Borody credited for saving Bob Hawke’s life

D’Alpuget credited Sydney gastroenterologist Thomas Borody — renowned globally for his innovative clinical work on complex gastrointestinal disorders — for saving the life of the great political slugger, devising the miraculous cocktail of specialist medicationss that saw the unsinkable Silver Bodgie live to slam another pint, though easy-drinking strawberry milkshakes are more his poison these […]

CDD news

Crestovo Doses Patients in PRISM 3, a Clinical Trial of CP101, a Microbiome Therapy for the Prevention of Recurrent Clostridium difficile Infection

CP101 is the lead, orally-administered product generated from Crestovo’s Full-Spectrum MicrobiotaTM (FSMTM) platform PRISM 3 includes 240 patients at clinical sites with broad coverage throughout the U.S. The company is based on foundational clinical research from gut microbiota-based treatment pioneers, Dr. Thomas J. Borody, Dr. Alexander Khoruts and Dr. Michael J. Sadowsky June 27, 2017 […]

CDD news

Microbiome leader Professor Borody calls for a National Australian FMT Bank to fight Drug Resistant Diseases

SYDNEY, AUS, May 19, 2017 – (ACN Newswire) – Faecal Microbiota Transplantation (FMT) leader Professor Thomas Borody (MD, PhD) has called for a national faecal bank to fight drug resistant and epidemic diseases in hospitals and clinics across the country. Professor Borody, the Founder and Medical Director of the Centre for Digestive Diseases (CDD) in […]

CDD featured in the media, CDD news

Fecal Microbiota Transplant Induces Steroid-free Remission in Ulcerative Colitis Patients, Study Reports

A clinical study found that multi-donor fecal microbiota transplantation (FMT) successfully induced clinical and endoscopic remission in patients with resistant active ulcerative colitis (UC). Results from the placebo-controlled trial were presented at the recent 11th Congress of the European Crohn’s and Colitis Organisation (ECCO), held in Amsterdam, the Netherlands. Read more 

CDD news
  • 1
  • 2